ACR Convergence 2020

November 5-9, 2020. All Virtual.

View by Number View by Title View Sessions

View by Date

Friday, November 6, 2020

9:00AM-11:00AM: Abstract Number: 0094

Validation Study of Proposed Diagnostic Criteria for Sympathetic Joint Effusion

Miscellaneous Rheumatic & Inflammatory Diseases Poster I: Diagnosis and Testing

9:00AM-11:00AM: Abstract Number: 0152

Veterans with RA and Gout Identify Their Goals and How They Can Work with Clinicians to Achieve Their Goals

Patient Outcomes, Preferences, & Attitudes Poster I: RA, Spondyloarthritis, & OA

9:00AM-11:00AM: Abstract Number: 0244

What Are the Early versus Late Predictors for Systemic Lupus Erythematosus (SLE) Diagnosis?

SLE – Diagnosis, Manifestations, & Outcomes Poster I: Clinical Manifestations

9:00AM-11:00AM: Abstract Number: 0164

What’s in a Name? Patient and Family Perspectives on the Naming of Systemic Juvenile Idiopathic Arthritis

Patient Outcomes, Preferences, & Attitudes Poster I: RA, Spondyloarthritis, & OA

9:00AM-11:00AM: Abstract Number: 0040

Whole Blood RNA Expression in Clinically Suspected Arthralgia Patients Shows a Potential Value in Prediction of Inflammatory Arthritis

Genetics, Genomics & Proteomics Poster

9:00AM-11:00AM: Abstract Number: 0331

Work Absenteeism and Disability Associated with Psoriatic Arthritis and Psoriasis in the United States – A Retrospective Study of Claims Data from 2009 to 2020

Spondyloarthritis Including Psoriatic Arthritis – Diagnosis, Manifestations, & Outcomes Poster I: Psoriatic Arthritis

9:00AM-11:00AM: Abstract Number: 0165

Work Disability and Predictors of Poor Work Outcome in Patients with Axial Spondyloarthritis

Patient Outcomes, Preferences, & Attitudes Poster I: RA, Spondyloarthritis, & OA

10:00AM-10:50AM: Abstract Number: 0454

Anticytokine Therapies for Inflammatory Rheumatic Disease (IRD) Are Associated with Reduced Hospitalisation Following Community COVID-19 Infection; Results of the Trinity Rheumatology and Covid-19 Registry – TRACR

Infection-related Rheumatic Disease (0454–0458)

10:00AM-10:50AM: Abstract Number: 0474

Assessment of Teaching Behavior and Knowledge Among Faculty to Inform an Active Teaching Intervention Within a Rheumatology Fellowship Curriculum

Professional Education (0474–0478)

10:00AM-10:50AM: Abstract Number: 0459

Autologous Hematopoietic Stem Cell Transplantation for Behçet’s Disease: A Retrospective Survey of Patients Treated in Europe, on the Behalf of the Autoimmune Diseases Working Party of the European Society for Blood and Bone Marrow Transplantation

Miscellaneous Rheumatic & Inflammatory Diseases I: Mechanisms of Disease (0459–0463)

10:00AM-10:50AM: Abstract Number: 0444

Chronological Order of Decrease of Synovitis, Osteitis and Tenosynovitis in Early Arthritis Patients Receiving First DMARD-treatment

Imaging of Rheumatic Diseases (0444–0448)

10:00AM-10:50AM: Abstract Number: 0448

Disease-related factors associated to atherosclerotic disease in axial spondyloarthritis. A mutlicenter study with 806 patients.

Imaging of Rheumatic Diseases (0444–0448)

10:00AM-10:50AM: Abstract Number: 0445

Dual-Energy CT in Gout Patients: Do All Color-Coded Lesions Actually Represent Monosodium Urate Crystals?

Imaging of Rheumatic Diseases (0444–0448)

10:00AM-10:50AM: Abstract Number: 0461

High-Throughput Single-Cell Analysis Reveals Unique Lung Cellular Subsets in a Murine Model of Rheumatoid Arthritis-Inflammatory Lung Disease

Miscellaneous Rheumatic & Inflammatory Diseases I: Mechanisms of Disease (0459–0463)

10:00AM-10:50AM: Abstract Number: 0455

HLA-B27 and Host Immune Response: Lessons from Reactive Arthritis

Infection-related Rheumatic Disease (0454–0458)

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].